Michael Millward

Professor, MB BS W.Aust., MA Melb., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 6025 Citations
  • 32 h-Index
20042021
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Cancer
  • Clinical trials

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 24 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Mutation Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2021

Research Output 2004 2018

A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Wu, J., Paton, V., Wang, L. & Gao, B., Aug 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 58-59 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Mu, S., Paton, V., Wang, L. & Gao, B., 10 Feb 2018, In : Journal of Clinical Oncology. 36, 5, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2 Citations

A Phase i study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours

Dredge, K., Brennan, T. V., Hammond, E., Lickliter, J. D., Lin, L., Bampton, D., Handley, P., Lankesheer, F., Morrish, G., Yang, Y., Brown, M. P. & Millward, M., 1 Apr 2018, In : British Journal of Cancer. 118, 8, p. 1035-1041 7 p.

Research output: Contribution to journalArticle

Safety
Neoplasms
Epistaxis
Maximum Tolerated Dose
Plasma Cells

Concordance of genomic mutations in tissue vs circulating tumour DNA (ctDNA) in metastatic melanoma

Calapre, L., Giardina, T., Robinson, C., Reid, A., Al-Ogaili, Z., Pereira, M., Mcevoy, A. C., Warburton, L., Khattak, M. A., Meniawy, T., Millward, M., Amanuel, B., Ziman, M. & Gray, E., Mar 2018, In : CLINICAL & EXPERIMENTAL METASTASIS. 35, 3, p. 187-187 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

McEvoy, A. C., Warburton, L., Al-Ogaili, Z., Celliers, L., Calapre, L., Pereira, M. R., Khattak, M. A., Meniawy, T. M., Millward, M., Ziman, M. & Gray, E. S., 9 Jul 2018, In : BMC Cancer. 18, 1, 726

Research output: Contribution to journalArticle

Open Access
Tumor Burden
Melanoma
DNA
Neoplasms
Polymerase Chain Reaction